Marshall Wace’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Marshall Wace's NVS Position: Q1 2026 in Review
Marshall Wace reduced its Novartis (NVS) stake by 54% in Q1 2026, selling an estimated $56.9M and leaving 322,056 shares worth $49.2M. The position accounts for 0.05% of the portfolio, ranked #365.
Marshall Wace first reported a position in NVS in Q4 2014 and has held it in 24 quarters since. The position peaked at $173M in Q2 2025. 1,591 funds tracked by Wall St. Rank hold NVS as of Q1 2026.
- Marshall Wace held 322,056 shares of Novartis worth $49.2M as of Q1 2026.
- Marshall Wace sold 371,300 Novartis shares in Q1 2026, an estimated $56.9M.
- Novartis made up 0.05% of Marshall Wace's portfolio in Q1 2026, its #365 holding.
- Marshall Wace first reported a position in Novartis in Q4 2014 and has held it in 24 quarters since.
- Marshall Wace's Novartis position peaked at $173M in Q2 2025.
- 1,591 funds tracked by Wall St. Rank held Novartis as of Q1 2026.
Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.